Therapeutic Exploratory Phase 2 Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoholic Fatty Liver Disease(NAFLD) Except Cirrhosis
Clinical trial NCT02029586 · TERMINATED
Trial details
- NCT number
- NCT02029586
- Sponsor
- Yungjin Pharm. Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2014-11-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.